Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Antios Therapeutics
AddedFeb 13, 2024
UpdatedJun 18, 2026
Antios Therapeutics

Antios Therapeutics

Public

Antios Therapeutics: A global, clinical-stage biopharmaceutical company developing novel antiviral therapies.

HQ
Atlanta, GA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded as a clinical-stage biopharmaceutical company, Antios Therapeutics is dedicated to developing novel antiviral therapies to address unmet medical needs. With a global market focus, the company's core mission is to innovate and provide effective treatments for viral infections, aiming to improve patient outcomes and overall public health.

Antios Therapeutics has garnered attention from notable investors and industry experts, contributing to its rapid advancements in antiviral research. Key achievements include significant progress in clinical trials and the development of promising therapeutic candidates. The company's impact is reflected in its potential to revolutionize antiviral treatment options, offering hope to patients worldwide.

Antios Therapeutics - Similar Companies

Aligos Therapeutics logo

Aligos Therapeutics

aligos.com

Antiva Biosciences logo

Antiva Biosciences

antivabio.com

Retrovirox logo

Retrovirox

retrovirox.com

Anthos Therapeutics logo

Anthos Therapeutics

Via Nova Therapeutics logo

Via Nova Therapeutics

vianovatx.com

Chimerix logo

Chimerix

Kovina Therapeutics logo

Kovina Therapeutics

kovina.com

Globavir Biosciences logo

Globavir Biosciences

Atea Pharmaceuticals logo

Atea Pharmaceuticals

ateapharma.com

Ansun Biopharma logo

Ansun Biopharma

ansunbiopharma.com

CoviCept Therapeutics logo

CoviCept Therapeutics

Arisan Therapeutics logo

Arisan Therapeutics

arisanthera.com

Altiris Therapeutics logo

Altiris Therapeutics

Red Queen Therapeutics logo

Red Queen Therapeutics

redqueentx.com

Intergalactic Therapeutics logo

Intergalactic Therapeutics

Antios Therapeutics - Quick Facts

Who are Antios Therapeutics' competitors?

Companies similar to Antios Therapeutics include Aligos Therapeutics, Antiva Biosciences, Retrovirox and Anthos Therapeutics.

When was Antios Therapeutics founded?

Antios Therapeutics was founded in 2018.

Where is Antios Therapeutics' headquarters located?

Antios Therapeutics' headquarters is located in Atlanta, GA, US.

When was Antios Therapeutics' last funding round?

Antios Therapeutics' most recent funding round was for $75M (USD) in November 2021.

How much has Antios Therapeutics raised to-date?

As of Nov 3, 2021, Antios Therapeutics has raised a total of $200.4M (USD).

How many employees does Antios Therapeutics have?

Antios Therapeutics has 35 employees as of Feb 5, 2024.

Antios Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Antiviral Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research